Now accepting Telehealth appointments. Schedule a virtual visit.

Transcranial Magnetic Stimulation Therapy for Patients with Major Depression

Major depression is the most commmon mental illnesses that many Americans face. Conventional approaches like talk therapy and antidepressants can work for some but not for all causing their symptoms to persist even after several treatments. Transcranial Magnetic Stimulation (TMS) is a new approach that is becoming more conventional for treatment resistant depresssion. 

One of the most extensive trials on TMS found that 47 percent of patients with treatment-resistant depression responded positively. Of those, nearly one-third experienced a full remission of their depression. While these results aren't always permanent, the mood benefits associated with TMS usually persist for many months after the end of treatment. On average, patients will experience more than a year of improved symptoms after completing a series of TMS sessions.

There's also a limited but growing body of evidence that suggests TMS may be useful in treating mental illness other than depression, like pediatric depression, bipolar disorder, and PTSD. However, TMS isn't approved yet for treating these conditions — future research is necessary.

 

Click the link here to read the whole story: 

https://www.news-medical.net/health/Transcranial-Magnetic-Stimulation-Therapy-for-Depression.aspx#1

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).